+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Pharmaceutical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • PDF Icon


  • 100 Pages
  • February 2024
  • Region: Asia Pacific
  • Mordor Intelligence
  • ID: 5459052
The Asia Pacific Pharmaceutical Packaging Market size is estimated at USD 41.66 billion in 2024, and is expected to reach USD 58.41 billion by 2029, growing at a CAGR of 6.99% during the forecast period (2024-2029).

The demand for pharmaceutical packaging is majorly emerging from densely populated economies like India and China. The increasing pharmaceutical production in these countries has been further boosting the demand.

Key Highlights

  • The Chinese government's policies to accelerate the transformation of the country's medical regime are expected to promote the development of the pharmaceutical packaging sector. Furthermore, China is actively upgrading its pharmaceutical packaging facilities and materials and diversifying its pharmaceutical products, which will likely bring new opportunities to pharmaceutical packaging firms. For instance, the Chinese government announced its ten-year 'Made in China 2025' strategic plan to make the country a global leader in several high-tech industries. These industries unexpectedly also included biotech, which was not a particularly strong area for Chinese manufacturing, which is more recognized for generics production. The government has dramatically increased its investment in and support for biotech to stimulate innovation. Advanced biologic production involving cell and gene therapies is currently limited but concentrated in Eastern China in provinces such as Shanghai, Zhejiang, and Jiangsu for US FDA-approved sites.
  • The shifting inclination of the manufacturers towards sustainable packaging solutions and partnerships between the market players opting the various way of growth for the market. For instance, in December 2022, Four Japanese drugmakers, Astellas, Eisai, Daiichi Sankyo, and Takeda, joined a partnership to reduce the environmental impact of pharmaceutical packaging. The collaboration comes as the pharma industry is increasingly having to face up to its effect on the environment after years of avoiding scrutiny of its impact as a significant manufacturer of goods.
  • Increasing advancement of technology in the packaging solutions of pharmaceuticals to provide advanced usages to the packaging solutions of medicines is further increasing the market's growth. For instance, the current advancement of the packaging design field, like zip lock bags, is lightweight and compact in securing medicine. Furthermore, the future of prefilled syringes will give patients hassle-free and subcutaneous options for drug delivery.
  • Moreover, aluminum and glass have traditionally been the preferred materials for pharmaceutical packaging. Over time, these materials became too expensive (due to raw material prices and other factors) to provide a commercially viable solution for packaging high-volume products, marking the demand for plastic materials in the industry.
  • The outbreak of the COVID-19 pandemic had a considerable impact across various industries, including the packaging industry, as the widespread lockdown and restriction on workforce utilization in factories significantly impacted demand and production and disrupted the supply of finished goods. The COVID-19 pandemic directly affected production and demand, disrupting pharmaceutical supply chains and logistics. As the industry shifted focus and prioritized infectious diseases and vaccines, successful clinical trials and R&D activities in therapeutic areas, such as diabetes and hypertension, decreased. However, the pharmaceutical industry recovered quickly with the need for safe and hygienic packaging during the pandemic. Further, the Russia-Ukraine war has an impact on the overall packaging ecosystem.

Asia Pacific Pharmaceutical Packaging Market Trends

Glass Packaging is Expected to Witness Significant Growth

  • Glass packaging is offered mainly as the primary packaging for pharmaceutical products and is among the leading packaging materials for the pharmaceutical industry. This is primarily due to advantages such as being sustainable, inert, impermeable, recyclable with no loss in quality, and reusable. Glass containers are among the primary packaging materials that have found significant use in the pharmaceutical industries.
  • The glass shows great ability in controlling and storing pharmaceuticals. Many pharmaceutical products are packed in glass containers because they can offer safety in a wide variety of environments. Daiichi Glass has developed pharmaceutical bottles such as lightweight vial bottles for injection and lightweight PS bottles for tablets.
  • The market growth is supported by the increase in glass container shipments in end-use markets. Glass containers are one of the most preferred materials for packaging liquid-based pharmaceutical products, chemicals, and other perishable/non-perishable products. Moreover, the rising preference for environment-friendly packaging solutions impacts pharmaceutical glass packaging adoption. The APAC Region is witnessing an increased demand for Glass packaging, the most common material used in pharmaceutical packaging, because of its characteristics that allow for easy sanitation and transparency of its substance.
  • Moreover, the rapidly increasing demand for injectable pharmaceuticals is also significantly driving the growth of glass-based products in the pharmaceutical sector. The market for oncology and other high-potency drugs such as steroids, antibody conjugates, and IV fluids that require quick onset of action is also expected to be a key growth driver.
  • The introduction of stringent laws to enhance the quality and integrity of domestically manufactured drugs has led to an increase in the usage of glass for pharmaceutical packaging solutions. Also, the rising demand for sterile medical packaging products from the industry would further drive the market's growth over the forecast period. Additionally, the market has an increasing recycling glass cost, and many companies have expanded their production capacities and manufacturing capabilities due to the COVID-19 pandemic.
  • According to a report from the Japanese Containers and Packaging Recycling Association, the cost of recycling brown glass in Japan reached JPY 8.2 thousand (USD 0.0567 thousand) per ton by 2023. In the past year, figures have been increasing on a steady basis and reaching their peak. Companies may be encouraged to invest in research and development for new packaging technologies due to the increased recycling costs associated with Brown Glass. Creating new materials and packaging designs that are more environmentally friendly and cost-effective can also be part of this. This innovation can make it possible for the pharmaceutical glass market in the Asia-Pacific to grow by providing better packaging solutions.

India is Expected to Witness Significant Growth

  • The pharmaceutical packaging industry has been experiencing substantial growth for several years. Due to innovations and emerging treatments, there is room for further growth in this section of the pharma industry. The COVID-19 pandemic brought a new awareness of the need to package and distribute products efficiently. There will likely be expectations to manufacture and distribute products quicker, right down to the packaging. Packaging companies are expected to face new pressures to develop solutions to get things moving faster and increase demand.
  • The investment of the packaging vendors is growing rapidly, contributing to the market's growth. For example, in February 2023, Telangana Government announced an INR 500 crore (USD 61 million) investment in the pharma industry. A collaboration between Corning Incorporated and SGD Pharma, a pharmaceutical primary packaging company. The collaboration facility for pharmaceutical packaging and glass production will be established in Telangana.
  • Furthermore, in May 2022, Gerresheimer ramped up pharma packaging capacity in India. The company has significantly ramped up its glass and plastic production capacities in India with new facilities and capabilities. By adding capacities in India, Gerresheimer executes its growth strategy in Emerging Markets, addressing the global megatrend for increasing healthcare access in these markets and the rising demand for vaccination.
  • The initiative taken by the Indian government to improve the healthcare sector is also one of the important factors for market growth. The Government of India introduced the Production Linked Incentive (PLI) scheme to encourage domestic manufacturing and achieve an AtmanirbharBharat. The adoption and compliance with regulatory norms in pharmaceutical packaging and standards about packaging recycling have bolstered the growth of the pharmaceutical packaging market in India.
  • In June 2022, India had multiple challenges, and providing the best healthcare to a burgeoning population was one of the most critical tasks. Despite improvements in the healthcare sector, chronic diseases are surging rapidly. As per a WHO report, 20% of the country's population suffers from at least one non-communicable disease, and the treatments are estimated to cost India USD 6.2 trillion by 2030. Research and development at pharmaceutical companies have driven the growth of the pharmaceutical packaging market in India.
  • According to Moneycontrol, as of July 2022, Cipla was the leading pharmaceutical business in India, with a net profit of approximately INR 30 billion (USD 0.36 billion). Divis Labs and Glenmark came in second and third, with net profits of around INR 29 billion (USD 0.35 billion) and INR 20 billion (USD 0.24 billion) during the specified time frame, respectively. Increasing a pharmaceutical company's net profit can contribute to increased demand for pharmaceutical products, investment in R&D, advanced packaging technologies, and increased outsourcing, all of which can help the pharmaceutical packaging market grow.

Asia Pacific Pharmaceutical Packaging Industry Overview

The Asia-Pacific Pharmaceutical Packaging Market is competitive, with many regional and global players. Some major players are Amcor Ltd., West Pharmaceutical Services, Inc., West Pharmaceutical Services, Inc., CCL Industries Inc., and NIPRO Corporation. Companies are increasing their market share by launching new products and expanding production units. Some of the recent developments are:

In December 2022, Amcor, responsible for packaging solutions, announced the opening of its new state-of-the-art manufacturing plant in Huizhou, China. With an investment of almost USD 100 million, the 590,000-square-foot plant was the largest flexible packaging plant by production capacity in China, further strengthening Amcor's ability to meet growing customer demand throughout Asia Pacific.

In November 2022, West Pharmaceutical Services, Inc. (West) recently extended its seal offerings in Indian and Asia Pacific markets by introducing Gamma Irradiated Flip-Off seals. West launched Gamma Irradiated Flip-Off seals to help pharmaceutical and biopharmaceutical manufacturers protect their products from external contamination while protecting drug quality. These seals were designed and developed to deliver consistent machinability, maintain container closure integrity, and support a safe, convenient user experience.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Industry Value Chain Analysis
4.3 Industry Attractiveness - Porter's Five Forces Analysis
4.3.1 Bargaining Power of Supplier
4.3.2 Bargaining Power of Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
4.4 Market Drivers
4.4.1 Increasing Adoption of Pharmaceutical Packaging in Emerging Economies
4.5 Market Restraints
4.5.1 Fluctuations in Raw Material Cost
5.1 By Material
5.1.1 Plastic
5.1.2 Paper and Paper Board
5.1.3 Glass
5.1.4 Aluminum Foil
5.2 By Type
5.2.1 Ampoules
5.2.2 Blister Packs
5.2.3 Plastic Bottles
5.2.4 Syringes
5.2.5 Vials
5.2.6 IV fluids
5.2.7 Other Types
5.3 By Drug Delivery Mode
5.3.1 Oral Drug packaging
5.3.2 Injectable Drug packaging
5.3.3 Pulmonary Drug Packaging
5.3.4 Other Drug Delivery Modes
5.4 By Country
5.4.1 India
5.4.2 Japan
5.4.3 China
5.4.4 Australia
5.4.5 Rest of Asia-Pacific
6.1 Company Profiles
6.1.1 Amcor Ltd.
6.1.2 CCL Industries Inc.
6.1.3 West Pharmaceutical Services, Inc
6.1.4 Gerresheimer AG
6.1.5 Schott AG
6.1.6 NIPRO Corporation
6.1.7 Wihuri Group
6.1.8 Klockner Pentaplast Group
6.1.9 Catalent Pharma Solutions, Inc.
6.1.10 Berry Global Group Inc.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amcor Ltd.
  • CCL Industries Inc.
  • West Pharmaceutical Services, Inc
  • Gerresheimer AG
  • Schott AG
  • NIPRO Corporation
  • Wihuri Group
  • Klockner Pentaplast Group
  • Catalent Pharma Solutions, Inc.
  • Berry Global Group Inc.